相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
Georgios N. Kalambokis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009
Maria Stepanova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: A cost-effectiveness analysis
Jasmohan S. Bajaj et al.
HEPATOLOGY (2012)
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study
Javier Fernandez et al.
HEPATOLOGY (2012)
Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience
Jasmohan S. Bajaj et al.
HEPATOLOGY (2012)
Durability of Rifaximin Response in Hepatic Encephalopathy
Guy W. Neff et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
A. Sanyal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
Sandeep Singh Sidhu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
GASTROENTEROLOGY (2011)
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis
D. L. Shawcross et al.
JOURNAL OF HEPATOLOGY (2011)
Review article: the modern management of hepatic encephalopathy
J. S. Bajaj
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy
Oliviero Riggio et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Drug Therapy: Rifaximin
Jasmohan S. Bajar et al.
HEPATOLOGY (2010)
Rifaximin in hepatic encephalopathy: More than just a non-absorbable antibiotic?
Rajiv Jalan
JOURNAL OF HEPATOLOGY (2010)
Mechanisms, diagnosis and management of hepatic encephalopathy
Ravi Prakash et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rifaximin for the Treatment of Hepatic Encephalopathy
P. S. Mantry et al.
TRANSPLANTATION PROCEEDINGS (2010)
Severe Sepsis in Cirrhosis
Thierry Gustot et al.
HEPATOLOGY (2009)
Outcomes in adult and pediatric liver transplantation among various ethnic groups
G. W. Neff et al.
TRANSPLANTATION PROCEEDINGS (2007)
The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis
E. Huang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy
Carroll B. Leevy et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Review article: the burden of hepatic encephalopathy
F. F. Poordad
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: A prospective randomized study
YH Paik et al.
YONSEI MEDICAL JOURNAL (2005)
Rifaximin: In vitro and in vivo antibacterial activity - A review
ZD Jiang et al.
CHEMOTHERAPY (2005)
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, doubledummy, controlled clinical trial
A Mas et al.
JOURNAL OF HEPATOLOGY (2003)
Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis
P Brigidi et al.
JOURNAL OF CHEMOTHERAPY (2002)
分享论文
